4.4 Article

A first-in-Asian phase 1 study to evaluate safety, pharmacokinetics and clinical activity of VS-6063, a focal adhesion kinase (FAK) inhibitor in Japanese patients with advanced solid tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity

Alan Serrels et al.

Review Pharmacology & Pharmacy

Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer

Alexander Schultze et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)

Review Pharmacology & Pharmacy

Targeting focal adhesion kinase signaling in tumor growth and metastasis

Joerg Schwock et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2010)

Article Oncology

Functional inactivation of NF2/merlin in human mesothelioma

Claudio Thurneysen et al.

LUNG CANCER (2009)

Review Oncology

Focal adhesion kinase as a regulator of cell tension in the progression of cancer

Robert W. Tilghman et al.

SEMINARS IN CANCER BIOLOGY (2008)

Review Biochemistry & Molecular Biology

Control of motile and invasive cell phenotypes by focal adhesion kinase

DD Schlaepfer et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2004)

Article Biochemistry & Molecular Biology

In vitro induction of bilirubin conjugation in primary rat hepatocyte culture

K Jemnitz et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)

Article Multidisciplinary Sciences

Mechanism of indinavir-induced hyperbilirubinemia

SD Zucker et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)